1. Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies. (6th October 2020) Authors: Saka, Hideo; Nishio, Makoto; Hida, Toyoaki; Nakagawa, Kazuhiko; Sakai, Hiroshi; Nogami, Naoyuki; Atagi, Shinji; Takahashi, Toshiaki; Horinouchi, Hidehito; Takenoyama, Mitsuhiro; Katakami, Nobuyuki; Tanaka, Hiroshi; Takeda, Koji; Satouchi, Miyako; Isobe, Hiroshi; Maemondo, Makoto; Goto, Koichi; Hi... Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 1(2021) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR). Issue 4 (20th July 2020) Authors: Okishio, Kyoichi; Morita, Ryo; Shimizu, Junichi; Saito, Haruhiro; Sakai, Hiroshi; Kim, Young Hak; Hataji, Osamu; Yomota, Makiko; Nishio, Makoto; Aoe, Keisuke; Kanai, Osamu; Kumagai, Toru; Kibata, Kayoko; Tsukamoto, Hiroaki; Oizumi, Satoshi; Fujimoto, Daichi; Tanaka, Hiroshi; Mizuno, Keiko; Masuda... Journal: ESMO open Issue: Volume 5:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗